Citryll is a pharmaceutical company engaged in the treatment of autoimmune and other human diseases such as lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis. It develops tACPA program, targeting the formation of neutrophil extracellular traps (NETs) to prevent or treat autoimmune diseases including rheumatoid arthritis.
|Employees (est.) (Oct 2020)||10|
Citryll total Funding
Citryll latest funding size
Time since last funding
|4 months ago|
|BioGeneration Ventures, Seventure, BOM Brabant Ventures, BrightGene, ModiQuest B.V., Curie Capital, ModiQuest|
When was Citryll founded?
Citryll was founded in 2019.
Who are Citryll key executives?
Citryll's key executives are Renato Chirivi and Marlon Dijkshoorn.
How many employees does Citryll have?
Citryll has 10 employees.
Who are Citryll competitors?
Competitors of Citryll include Anavex, Fratagene Therapeutics and Neuro-Bio.
Where are Citryll offices?
Citryll has an office in Oss.
How many offices does Citryll have?
Citryll has 1 office.
Receive alerts for 300+ data fields across thousands of companies